FDA Grants Clearance to Luminex for Molecular Test

August 3, 2016

Luminex has received FDA clearance for the Aries Flu A/B & RSV assay.

The molecular testing device delivers results in less than two hours for the detection and differentiation of influenza A virus, influenza B virus, and respiratory syncytial virus, the company stated.

This is the second assay the FDA has cleared for use on the Luminex Aries system. — Cynthia Jessup

View today's stories